Characteristics | Number of Patients (n) | Percentage |
---|---|---|
Tumor-localization | ||
central | 53 | 26.2% |
peripheral | 149 | 73.8% |
Histology | ||
adenocarcinoma | 117 | 57.4% |
SCCa | 75 | 36.8% |
others | 12 | 5.9% |
Grading | ||
In situ | 2 | 1% |
G1 | 25 | 12.4% |
G2 | 95 | 47.0% |
G3 | 68 | 33.3% |
G4 | 12 | 5.9% |
pT-category | ||
pTis | 2 | 1% |
pT1 | 90 | 45.1% |
pT1a | 10 | 4.9% |
pT1b | 37 | 18.1% |
pT1c | 43 | 21.1% |
pT2 | 44 | 26.5 |
pT2a | 39 | 19.1% |
pT2b | 15 | 7.4% |
pT3 | 35 | 17.2% |
pT4 | 23 | 11.3 |
pN-category | ||
pN0 | 126 | 61.8% |
pN1 | 33 | 16.2% |
pN2 | 45 | 22% |
pM-category | ||
pM0 | 193 | 94.5% |
pM1a | 5 | 2.5% |
pM1b | 5 | 2.5% |
pM1c | 1 | 0.5% |
pL-Status | ||
pL0 | 57 | 28.1% |
pL1 | 146 | 71.9% |
pV-Status | ||
pV0 | 165 | 81.3% |
pV1 | 38 | 18.7% |